Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.
Share:
More In Business
From Trick to Trend: Unreal Snacks CEO on Why Dye-Free Candy Is Taking Over
Unreal Snacks CEO Kevin McCarthy shares how dye-free candy is leading the sweets revolution—just in time for what could be a record-breaking Halloween 2025.
Poll Shows Growing Economic Anxiety Under Trump
A new AP-NORC poll finds Americans are increasingly worried about their ability to find good jobs and keep up with rising costs under President Trump.
The Louvre Heist: Thieves Pull Off Four-minute Jewel Job
In a daring daylight robbery on Sunday, thieves used a basket lift to scale the Louvre’s facade, smash display cases, and steal eight priceless jewels.
Trump Admin Reverses Course On Student Loan Forgiveness
The Trump administration has agreed to resume processing student debt cancellations under two key income-driven repayment plans it had previously limited.
Trump Cuts Off Colombia: “No More Payments, No More Subsidies”
President Trump announced Sunday that the U.S. will halt all payments and subsidies to Colombia.
Americans Rally Against Trump In ‘No Kings’ Protests
Millions of protesters flooded cities nationwide on Saturday for “No Kings” demonstrations denouncing what they call President Donald Trump’s authoritarian turn
Passports of Privilege: Inside the World of Citizenship by Investment
Chris Willis, Managing Partner at Latitude Group, on how high-net-worth families are unlocking global access through strategic citizenship planning.
Credit Scores Made Simple: Kikoff’s Cynthia Chen on a Smarter Path
Cynthia Chen, CEO of Kikoff, shares how their membership app helps users build credit with zero fees, no interest, and smart tools that make every point count.
Big Business This Week: All about the shutdown economy
We spoke to an economist about the impact of the shutdown on the U.S. economy
